Wim Robberecht
#152,506
Most Influential Person Now
Wim Robberecht's AcademicInfluence.com Rankings
Wim Robberechtphilosophy Degrees
Philosophy
#8496
World Rank
#11889
Historical Rank
Logic
#5527
World Rank
#6933
Historical Rank
Wim Robberechtbiology Degrees
Biology
#11501
World Rank
#14901
Historical Rank
Neuroscience
#1867
World Rank
#1923
Historical Rank
Download Badge
Philosophy Biology
Why Is Wim Robberecht Influential?
(Suggest an Edit or Addition)Wim Robberecht's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis (2013) (1170)
- Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration (2001) (1032)
- The changing scene of amyotrophic lateral sclerosis (2013) (899)
- VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death (2003) (881)
- Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease. (2005) (860)
- A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study (2012) (630)
- Mutant small heat-shock protein 27 causes axonal Charcot-Marie-Tooth disease and distal hereditary motor neuropathy (2004) (581)
- Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barre syndrome (1997) (542)
- Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease (2011) (526)
- Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS (2005) (516)
- Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD/ALS (2015) (462)
- The phenotypic variability of amyotrophic lateral sclerosis (2014) (438)
- Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis (2016) (424)
- The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis. (2006) (420)
- Hot-spot residue in small heat-shock protein 22 causes distal motor neuropathy (2004) (414)
- Genome-wide Analyses Identify KIF5A as a Novel ALS Gene (2018) (414)
- HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1–induced Charcot-Marie-Tooth disease (2011) (400)
- Progranulin functions as a neurotrophic factor to regulate neurite outgrowth and enhance neuronal survival (2008) (367)
- MFN2 mutation distribution and genotype/phenotype correlation in Charcot-Marie-Tooth type 2. (2006) (366)
- Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis (2009) (358)
- A revision of the El Escorial criteria - 2015 (2015) (356)
- Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathy (2006) (350)
- A yeast functional screen predicts new candidate ALS disease genes (2011) (327)
- A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis (1998) (322)
- Minocycline delays disease onset and mortality in a transgenic model of ALS (2002) (311)
- Guidelines for preclinical animal research in ALS/MND: A consensus meeting (2010) (305)
- Variants of the elongator protein 3 (ELP3) gene are associated with motor neuron degeneration (2008) (274)
- EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans (2012) (273)
- Chromosome 9p21 in sporadic amyotrophic lateral sclerosis in the UK and seven other countries: a genome-wide association study (2010) (247)
- Abnormal intracellular ca(2+)homeostasis and disease. (2000) (238)
- Genetic variation in DPP6 is associated with susceptibility to amyotrophic lateral sclerosis (2008) (232)
- Ca2+-permeable AMPA receptors and selective vulnerability of motor neurons (2000) (226)
- HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUS-ALS patients (2017) (225)
- Drosophila screen connects nuclear transport genes to DPR pathology in c9ALS/FTD (2016) (222)
- ITPR2 as a susceptibility gene in sporadic amyotrophic lateral sclerosis: a genome-wide association study (2007) (215)
- Astrocytes regulate GluR2 expression in motor neurons and their vulnerability to excitotoxicity (2007) (214)
- The C9ORF72 expansion mutation is a common cause of ALS+/−FTD in Europe and has a single founder (2012) (213)
- Oligodendrocyte dysfunction in the pathogenesis of amyotrophic lateral sclerosis. (2013) (209)
- Quantitative diffusion tensor imaging in amyotrophic lateral sclerosis (2007) (201)
- Serum biomarker for progranulin‐associated frontotemporal lobar degeneration (2009) (200)
- NEK1 variants confer susceptibility to amyotrophic lateral sclerosis (2016) (195)
- Angiogenin variants in Parkinson disease and amyotrophic lateral sclerosis (2011) (184)
- AMPA Receptor Calcium Permeability, GluR2 Expression, and Selective Motoneuron Vulnerability (2000) (180)
- Recessive amyotrophic lateral sclerosis families with the D90A SOD1 mutation share a common founder: evidence for a linked protective factor. (1998) (175)
- Excitotoxicity and Amyotrophic Lateral Sclerosis (2006) (173)
- Expanded ATXN2 CAG repeat size in ALS identifies genetic overlap between ALS and SCA2 (2011) (159)
- Erratum: Amyotrophic lateral sclerosis (Nature reviews. Disease primers (2017) 3 (17071)) (2017) (151)
- Ablation of Proliferating Microglia Does Not Affect Motor Neuron Degeneration in Amyotrophic Lateral Sclerosis Caused by Mutant Superoxide Dismutase (2008) (150)
- Overexpression of mutant superoxide dismutase 1 causes a motor axonopathy in the zebrafish. (2007) (145)
- Progranulin genetic variability contributes to amyotrophic lateral sclerosis (2008) (145)
- GluR2-dependent properties of AMPA receptors determine the selective vulnerability of motor neurons to excitotoxicity. (2002) (145)
- Modelling amyotrophic lateral sclerosis: progress and possibilities (2017) (143)
- Rapid Communication: Cu/Zn Superoxide Dismutase Activity in Familial and Sporadic Amyotrophic Lateral Sclerosis (1994) (139)
- Upper and extra-motoneuron involvement in early motoneuron disease: a diffusion tensor imaging study. (2011) (138)
- Progranulin is Neurotrophic In Vivo and Protects against a Mutant TDP-43 Induced Axonopathy (2010) (135)
- Quantitative diffusion tensor imaging in amyotrophic lateral sclerosis: Revisited (2009) (132)
- D90A heterozygosity in the SOD1 gene is associated with familial and apparently sporadic amyotrophic lateral sclerosis (1996) (131)
- Modifiers of C9orf72 DPR toxicity implicate nucleocytoplasmic transport impairments in c9FTD/ALS (2015) (123)
- Progranulin mutations and amyotrophic lateral sclerosis or amyotrophic lateral sclerosis–frontotemporal dementia phenotypes (2006) (122)
- A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis. (2014) (121)
- The AMPA receptor antagonist NBQX prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis (2003) (120)
- Protective Effect of Parvalbumin on Excitotoxic Motor Neuron Death (2002) (118)
- Novel Role for Vascular Endothelial Growth Factor (VEGF) Receptor-1 and Its Ligand VEGF-B in Motor Neuron Degeneration (2008) (117)
- Oxidative stress in amyotrophic lateral sclerosis (2000) (117)
- A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis. European ALS/IGF-I Study Group. (1998) (116)
- Inhibition of p38 mitogen activated protein kinase activation and mutant SOD1G93A-induced motor neuron death (2007) (116)
- Efficacy and safety of xaliproden in amyotrophic lateral sclerosis: results of two phase III trials (2004) (116)
- GluR2 Deficiency Accelerates Motor Neuron Degeneration in a Mouse Model of Amyotrophic Lateral Sclerosis (2005) (116)
- Hdac6 deletion delays disease progression in the SOD1G93A mouse model of ALS. (2013) (116)
- Effects of vascular endothelial growth factor (VEGF) on motor neuron degeneration (2004) (116)
- Relative contribution of mutations in genes for autosomal dominant distal hereditary motor neuropathies: a genotype-phenotype correlation study. (2007) (116)
- UNC13A is a modifier of survival in amyotrophic lateral sclerosis (2012) (115)
- Value of 18fluorodeoxyglucose-positron-emission tomography in amyotrophic lateral sclerosis: a prospective study. (2014) (114)
- Benefit of the Awaji diagnostic algorithm for amyotrophic lateral sclerosis: A prospective study (2011) (110)
- Guidelines for the preclinical in vivo evaluation of pharmacological active drugs for ALS/MND: Report on the 142nd ENMC international workshop (2007) (108)
- Skeletal muscle properties in a transgenic mouse model for amyotrophic lateral sclerosis: effects of creatine treatment (2003) (108)
- Amyotrophic lateral sclerosis: pathogenesis. (2000) (108)
- A phase II−III trial of olesoxime in subjects with amyotrophic lateral sclerosis (2014) (107)
- Genetic correlation between amyotrophic lateral sclerosis and schizophrenia (2017) (107)
- Mutations in SACS cause atypical and late-onset forms of ARSACS (2010) (103)
- Mibefradil (Ro 40-5967) blocks multiple types of voltage-gated calcium channels in cultured rat spinal motoneurones. (1997) (102)
- Age of onset of amyotrophic lateral sclerosis is modulated by a locus on 1p34.1 (2013) (101)
- Influence of Arterial Input Function on Hypoperfusion Volumes Measured With Perfusion-Weighted Imaging (2003) (100)
- ELP3 Controls Active Zone Morphology by Acetylating the ELKS Family Member Bruchpilot (2011) (97)
- Project MinE: study design and pilot analyses of a large-scale whole-genome sequencing study in amyotrophic lateral sclerosis (2017) (97)
- Progranulin functions as a cathepsin D chaperone to stimulate axonal outgrowth in vivo (2017) (96)
- Upregulation of HSP27 in a Transgenic Model of ALS (2002) (95)
- Rare mutations in SQSTM1 modify susceptibility to frontotemporal lobar degeneration (2014) (93)
- Diffusion-weighted MRI in sporadic Creutzfeldt-Jakob disease (1999) (92)
- MRI of herpes simplex encephalitis (2004) (91)
- Neuronal inclusion protein TDP-43 has no primary genetic role in FTD and ALS (2009) (90)
- The neurobiology of amyotrophic lateral sclerosis (2010) (89)
- AMPA Receptor Current Density, Not Desensitization, Predicts Selective Motoneuron Vulnerability (2000) (87)
- Mutant HSPB8 causes motor neuron-specific neurite degeneration (2010) (86)
- A zebrafish model for C9orf72 ALS reveals RNA toxicity as a pathogenic mechanism (2018) (86)
- TBK1 Mutation Spectrum in an Extended European Patient Cohort with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis (2017) (85)
- Glatiramer acetate has no impact on disease progression in ALS at 40 mg/day: A double- blind, randomized, multicentre, placebo-controlled trial (2009) (85)
- Glial cells potentiate kainate-induced neuronal death in a motoneuron-enriched spinal coculture system (1998) (83)
- The G93C mutation in superoxide dismutase 1: clinicopathologic phenotype and prognosis. (2006) (83)
- Cell-to-cell communication in peptide target cells of anterior pituitary. (1989) (83)
- Meta-analysis of vascular endothelial growth factor variations in amyotrophic lateral sclerosis: increased susceptibility in male carriers of the −2578AA genotype (2008) (82)
- RNA toxicity in non‐coding repeat expansion disorders (2019) (82)
- Multicenter validation of CSF neurofilaments as diagnostic biomarkers for ALS (2016) (80)
- Increased sensitivity of fibroblasts from amyotrophic lateral sclerosis patients to oxidative stress (1998) (80)
- ATXN2 trinucleotide repeat length correlates with risk of ALS (2017) (77)
- HDAC6 is a therapeutic target in mutant GARS-induced Charcot-Marie-Tooth disease (2018) (76)
- VEGF protects motor neurons against excitotoxicity by upregulation of GluR2 (2010) (75)
- Pathogenic cysteine mutations affect progranulin function and production of mature granulins (2010) (74)
- Update of the pompe disease mutation database with 60 novel GAA sequence variants and additional studies on the functional effect of 34 previously reported variants (2012) (74)
- Noninvasive ventilation improves sleep in amyotrophic lateral sclerosis: a prospective polysomnographic study. (2015) (72)
- Recent advances in motor neuron disease (2009) (71)
- Molecular Dissection of FUS Points at Synergistic Effect of Low-Complexity Domains in Toxicity (2018) (67)
- Deletion or Inhibition of the Oxygen Sensor PHD1 Protects against Ischemic Stroke via Reprogramming of Neuronal Metabolism. (2016) (67)
- Microglial Upregulation of Progranulin as a Marker of Motor Neuron Degeneration (2010) (67)
- Multicentre quality control evaluation of different biomarker candidates for amyotrophic lateral sclerosis (2014) (66)
- Amyotrophic lateral sclerosis (2017) (66)
- Differentiation of hereditary spastic paraparesis from primary lateral sclerosis in sporadic adult-onset upper motor neuron syndromes. (2009) (65)
- RNA metabolism and the pathogenesis of motor neuron diseases (2010) (64)
- Evolution of motor and sensory deficits in amyotrophic lateral sclerosis estimated by neurophysiological techniques (1999) (64)
- Familial juvenile focal amyotrophy of the upper extremity (Hirayama disease). Superoxide dismutase 1 genotype and activity. (1997) (63)
- Efficacy and safety of Privigen® in patients with chronic inflammatory demyelinating polyneuropathy: results of a prospective, single-arm, open-label Phase III study (the PRIMA study) (2013) (61)
- Prevention of intestinal obstruction reveals progressive neurodegeneration in mutant TDP-43 (A315T) mice (2014) (60)
- Development of Improved HDAC6 Inhibitors as Pharmacological Therapy for Axonal Charcot–Marie–Tooth Disease (2016) (59)
- Rapamycin increases survival in ALS mice lacking mature lymphocytes (2013) (59)
- Association of a Locus in the CAMTA1 Gene With Survival in Patients With Sporadic Amyotrophic Lateral Sclerosis. (2016) (58)
- The neurotrophic properties of progranulin depend on the granulin E domain but do not require sortilin binding (2013) (58)
- Genome-wide association analyses in Han Chinese identify two new susceptibility loci for amyotrophic lateral sclerosis (2013) (57)
- C9orf72 and UNC13A are shared risk loci for amyotrophic lateral sclerosis and frontotemporal dementia: A genome‐wide meta‐analysis (2014) (56)
- Diffusion-weighted magnetic resonance imaging in Creutzfeldt-Jakob disease (1997) (56)
- Vascular endothelial growth factor counteracts the loss of phospho‐Akt preceding motor neurone degeneration in amyotrophic lateral sclerosis (2007) (56)
- TDP-43 M311V mutation in familial amyotrophic lateral sclerosis (2009) (55)
- Role of mitochondria in kainate-induced fast Ca2+ transients in cultured spinal motor neurons. (2007) (54)
- The role of oligodendroglial dysfunction in amyotrophic lateral sclerosis. (2014) (54)
- A large genome scan for rare CNVs in amyotrophic lateral sclerosis. (2010) (53)
- Different receptors mediate motor neuron death induced by short and long exposures to excitotoxicity (2000) (52)
- NIPA1 polyalanine repeat expansions are associated with amyotrophic lateral sclerosis. (2012) (52)
- Mapping of Gene Expression Reveals CYP27A1 as a Susceptibility Gene for Sporadic ALS (2012) (52)
- Chloride Influx Aggravates Ca2+-Dependent AMPA Receptor-Mediated Motoneuron Death (2003) (52)
- Translating biological findings into new treatment strategies for amyotrophic lateral sclerosis (ALS) (2014) (52)
- Benefits of intensive insulin therapy on neuromuscular complications in routine daily critical care practice: a retrospective study (2009) (51)
- Accuracy of diffusion-weighted MR imaging in the diagnosis of sporadic Creutzfeldt-Jakob disease (2003) (51)
- The occurrence of mutations in FUS in a Belgian cohort of patients with familial ALS (2010) (50)
- An α-mercaptoacrylic acid derivative (PD150606) inhibits selective motor neuron death via inhibition of kainate-induced Ca2+ influx and not via calpain inhibition (2002) (49)
- Variant on 9p21 strongly associates with coronary heart disease, but lacks association with common stroke (2009) (48)
- Elongator subunit 3 (ELP3) modifies ALS through tRNA modification (2018) (48)
- Crosstalk between astrocytes and motor neurons: What is the message? (2008) (48)
- Over‐expression of Hsp27 does not influence disease in the mutant SOD1G93A mouse model of amyotrophic lateral sclerosis (2008) (47)
- Ivermectin inhibits AMPA receptor-mediated excitotoxicity in cultured motor neurons and extends the life span of a transgenic mouse model of amyotrophic lateral sclerosis (2007) (47)
- Novel COL4A1 mutations cause cerebral small vessel disease by haploinsufficiency. (2013) (46)
- Inhibition of histone deacetylase 6 (HDAC6) protects against vincristine-induced peripheral neuropathies and inhibits tumor growth (2018) (46)
- Modifying expression of EphA4 and its downstream targets improves functional recovery after stroke. (2013) (46)
- Mutations in the Glycosyltransferase Domain of GLT8D1 Are Associated with Familial Amyotrophic Lateral Sclerosis (2019) (45)
- Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial (2017) (45)
- Myosin storage myopathy: Slow skeletal myosin (MYH7) mutation in two isolated cases (2005) (45)
- Pentoxifylline in ALS: a double-blind, randomized, multicenter, placebo-controlled trial. (2006) (43)
- Intravascular lymphomatosis of the brain: a diagnostic problem (1999) (43)
- Myasthenic syndrome caused by direct effect of chloroquine on neuromuscular junction. (1989) (42)
- Frequency of C9orf72 repeat expansions in amyotrophic lateral sclerosis: a Belgian cohort study (2013) (41)
- Cardiac involvement and CTG expansion in myotonic dystrophy (2002) (40)
- Pathogenic Huntingtin Repeat Expansions in Patients with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis (2020) (40)
- Manofluorographic evaluation of swallowing in amyotrophic lateral sclerosis and its relationship with clinical evaluation of swallowing (2006) (40)
- Exome sequencing reveals HINT1 mutations as a cause of distal hereditary motor neuropathy (2013) (40)
- Autosomal recessive spastic ataxia of Charlevoix-Saguenay (2009) (40)
- Vascular endothelial growth factor in amyotrophic lateral sclerosis and other neurodegenerative diseases (2006) (39)
- Demographic characteristics and prognosis in a Flemish amyotrophic lateral sclerosis population. (2000) (38)
- Prospective Validation of 18F-FDG Brain PET Discriminant Analysis Methods in the Diagnosis of Amyotrophic Lateral Sclerosis (2016) (38)
- Genetic variant in the HSPB1 promoter region impairs the HSP27 stress response (2007) (38)
- Pathological findings in a patient with amyotrophic lateral sclerosis and multifocal motor neuropathy with conduction block (1996) (36)
- VEGF modulates NMDA receptors activity in cerebellar granule cells through Src-family kinases before synapse formation (2011) (36)
- Non-invasive ventilation in amyotrophic lateral sclerosis (2013) (35)
- Deletion in the CMT1A locus on chromosome 17p11.2 in hereditary neuropathy with liability to pressure palsies (1994) (35)
- Role of matrix metalloproteinase-9 in a mouse model for amyotrophic lateral sclerosis (2005) (34)
- C9orf72 expansion differentially affects males with spinal onset amyotrophic lateral sclerosis (2016) (34)
- Whole-genome sequencing reveals a coding non-pathogenic variant tagging a non-coding pathogenic hexanucleotide repeat expansion in C9orf72 as cause of amyotrophic lateral sclerosis (2012) (33)
- Subcellular localization of calcium‐permeable AMPA receptors in spinal motoneurons (2001) (33)
- Neurofibromatosis type I gene mutation in a patient with features of LEOPARD syndrome (1996) (32)
- Mutational analysis of the Cu/Zn superoxide dismutase gene in 23 familial and 69 sporadic cases of amyotrophic lateral sclerosis in Belgium (1999) (32)
- FUS-induced neurotoxicity in Drosophila is prevented by downregulating nucleocytoplasmic transport proteins (2018) (32)
- Genetics of amyotrophic lateral sclerosis (2000) (29)
- Progranulin reduces insoluble TDP-43 levels, slows down axonal degeneration and prolongs survival in mutant TDP-43 mice (2018) (29)
- Role of heat shock response and Hsp27 in mutant SOD1-dependent cell death (2006) (29)
- Microglia in amyotrophic lateral sclerosis. (2007) (28)
- ATXN1 repeat expansions confer risk for amyotrophic lateral sclerosis and contribute to TDP-43 mislocalization (2020) (28)
- Stimulation and inhibition of pituitary growth hormone release by angiotensin II in vitro. (1988) (27)
- Stimulation of prolactin secretion from rat pituitary by luteinizing hormone-releasing hormone: evidence against mediation by angiotensin II acting through a (Sar1-Ala8)-angiotensin II-sensitive receptor. (1992) (27)
- Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis (2021) (27)
- No evidence for shared genetic basis of common variants in multiple sclerosis and amyotrophic lateral sclerosis. (2014) (26)
- C9orf72 and UNC13A are shared risk loci for ALS and FTD: A genome-wide meta-analysis (2014) (26)
- Lymphocytic infundibulohypophysitis presenting in the postpartum period: case report. (1996) (26)
- H63D polymorphism in HFE is not associated with amyotrophic lateral sclerosis (2013) (25)
- Exome array analysis of rare and low frequency variants in amyotrophic lateral sclerosis (2019) (25)
- Differential contribution of the Na+‐K+‐2Cl− cotransporter NKCC1 to chloride handling in rat embryonic dorsal root ganglion neurons and motor neurons (2009) (25)
- Clinical implications of recent breakthroughs in amyotrophic lateral sclerosis (2013) (25)
- CuZn-Superoxide Dismutase in D90A Heterozygotes from Recessive and Dominant ALS Pedigrees (2002) (25)
- Analysis of the KIFAP3 gene in amyotrophic lateral sclerosis: a multicenter survival study (2014) (24)
- Analysis of FGGY as a risk factor for sporadic amyotrophic lateral sclerosis (2009) (24)
- Reconsidering the causality of TIA1 mutations in ALS (2018) (23)
- Purulent meningitis due to aspergillosis in a patient with systemic lupus erythematosus (1992) (23)
- The cellular mRNA expression of GABA and glutamate receptors in spinal motor neurons of SOD1 mice (2005) (22)
- Rare Variant Burden Analysis within Enhancers Identifies CAV1 as an ALS Risk Gene (2020) (22)
- Hypersensitivity pneumonitis possibly caused by riluzole therapy in ALS (2003) (22)
- CHCHD10 variants in amyotrophic lateral sclerosis: Where is the evidence? (2018) (21)
- Association of NIPA1 repeat expansions with amyotrophic lateral sclerosis in a large international cohort (2019) (21)
- A genome-wide association meta-analysis identifies a novel locus at 17 q 11 . 2 associated with sporadic amyotrophic lateral sclerosis (2014) (21)
- Astrocyte-derived Jagged-1 mitigates deleterious Notch signaling in amyotrophic lateral sclerosis (2018) (19)
- Calcium handling proteins in isolated spinal motoneurons. (1999) (19)
- Cochlear supporting cell transdifferentiation and integration into hair cell layers by inhibition of ephrin-B2 signalling (2015) (19)
- Beta-2 microglobulin is important for disease progression in a murine model for amyotrophic lateral sclerosis (2013) (18)
- Genetic ablation of phospholipase C delta 1 increases survival in SOD1G93A mice (2013) (18)
- Heterogeneity in motoneuron disease (2007) (18)
- Tau levels do not influence human ALS or motor neuron degeneration in the SOD1G93A mouse (2010) (18)
- Genetic ablation of IP3 receptor 2 increases cytokines and decreases survival of SOD1G93A mice (2016) (17)
- Coincidence of developmental venous anomalies and other brain lesions: a clinical study (1995) (17)
- Minocycline for patients with ALS (2008) (17)
- Painful muscle spasms complicating algodystrophy: central or peripheral disease? (1988) (16)
- Prognostic value of clinical and electrodiagnostic parameters at time of diagnosis in patients with amyotrophic lateral sclerosis (2017) (16)
- TNFRSF1A coding variants in multiple sclerosis (2011) (16)
- Structural variation analysis of 6,500 whole genome sequences in amyotrophic lateral sclerosis (2022) (16)
- Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studies (2019) (15)
- Coexistence of CADASIL and Alzheimer’s disease (2003) (15)
- Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studies (2019) (15)
- Developments in treatments for amyotrophic lateral sclerosis via intracerebroventricular or intrathecal delivery (2014) (14)
- Na(+) entry through AMPA receptors results in voltage-gated k(+) channel blockade in cultured rat spinal cord motoneurons. (2002) (14)
- The genetic basis of amyotrophic lateral sclerosis: recent breakthroughs (2015) (14)
- Dantrolene is neuroprotective in vitro, but does not affect survival in SOD1G93A mice (2012) (14)
- Copper and zinc levels in familial amyotrophic lateral sclerosis patients with cuznsod gene mutations (1997) (14)
- Focal leptomeningeal MR enhancement along the chiasm as a presenting sign of multiple sclerosis. (1995) (14)
- Neuronal overexpression of IP₃ receptor 2 is detrimental in mutant SOD1 mice. (2012) (13)
- Identification and characterization of Nanobodies targeting the EphA4 receptor (2017) (13)
- Neurodegenerative phenotypes in an A 53 T a-synuclein transgenic mouse model are independent of LRRK 2 (2012) (12)
- A retrospective study of Creutzfeldt–Jakob disease in Belgium (1999) (12)
- Angiotensin II is retained in gonadotrophs of pituitary cell aggregates cultured in serum-free medium but does not mimic the effects of exogenous angiotensins and luteinizing-hormone-releasing hormone on growth hormone release. (1992) (12)
- Response of mouse brain perfusion to hypo‐ and hyperventilation measured by arterial spin labeling (2011) (12)
- Progranulin does not affect motor neuron degeneration in mutant SOD1 mice and rats (2013) (11)
- EphA4 loss improves social memory performance and alters dendritic spine morphology without changes in amyloid pathology in a mouse model of Alzheimer’s disease (2019) (11)
- Lack of improvement with ceftriaxone in motoneuron disease (1992) (11)
- AAV9-mediated gene delivery of MCT1 to oligodendrocytes does not provide a therapeutic benefit in a mouse model of ALS (2021) (11)
- Molecular genetic analysis of the 17p11.2 region in patients with hereditary neuropathy with liability to pressure palsies (HNPP) (2004) (10)
- Genome-wide association analyses in Han Chinese identify two new susceptibility loci for amyotrophic lateral sclerosis (2013) (10)
- Peripheral neuropathy and 46XY gonadal dysgenesis: A heterogeneous entity (2009) (10)
- Tissue‐type plasminogen activator is not required for kainate‐induced motoneuron death in vitro (1998) (10)
- Modeling neurodegenerative diseases in zebrafish embryos. (2011) (10)
- SCFD1 expression quantitative trait loci in amyotrophic lateral sclerosis are differentially expressed (2021) (10)
- Intracerebroventricular delivery of vascular endothelial growth factor in patients with amyotrophic lateral sclerosis, a phase I study (2020) (9)
- Polymorphisms in the GluR2 gene are not associated with amyotrophic lateral sclerosis (2012) (9)
- Pentoxifylline in ALS (2006) (8)
- Long-lasting changes in GABA responsiveness in cultured neurons (2004) (8)
- Minimum clinically important difference analysis confirms the efficacy of IgPro10 in CIDP: the PRIMA trial (2017) (8)
- Minimum clinically important difference analysis confirms the efficacy of IgPro10 in CIDP: the PRIMA trial (2017) (8)
- Environmental enrichment during the chronic phase after experimental stroke promotes functional recovery without synergistic effects of EphA4 targeted therapy (2019) (8)
- Genetic markers of ALS. (2000) (8)
- A novel 7.4 kb mitochondrial deletion in a patient with congenital progressive external ophthalmoplegia, muscle weakness and mental retardation. (1999) (7)
- Reduction of ephrin-A5 aggravates disease progression in amyotrophic lateral sclerosis (2019) (7)
- A case of hemiparesis associated with cranial nerve lesions due to intravascular lymphomatosis (2003:4b) (2003) (7)
- Neurocysticercosis: a poorly understood disease. (1995) (6)
- In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration (2018) (6)
- Reducing EphA4 before disease onset does not affect survival in a mouse model of Amyotrophic Lateral Sclerosis (2019) (6)
- Association of a Locus in the CAMTA 1 GeneWith Survival in PatientsWith Sporadic Amyotrophic Lateral Sclerosis (2016) (6)
- Meningitis due toNeisseria meningitidis with intermediate susceptibility to penicillin (1993) (6)
- Heterozygous Deletion of EphrinA5 Does Not Improve Functional Recovery After Experimental Stroke (2019) (6)
- Conditional deletion of Id2 or Notch1 in oligodendrocyte progenitor cells does not ameliorate disease outcome in SOD1G93A mice (2018) (6)
- Distal myopathy as the presenting manifestation of sarcoidosis. (1995) (6)
- Unilateral white matter involvement in Krabbe disease. (2011) (5)
- Reverse transcriptase takes ALS back to viruses (2005) (5)
- Enhanced ANG II activity in anterior pituitary cell aggregates from hypertensive rats. (1988) (5)
- Whole-genome sequencing reveals a coding non-pathogenic variant tagging a non-coding pathogenic hexanucleotide repeat expansion in C 9 orf 72 as cause of amyotrophic lateral sclerosis (2012) (5)
- The Effect of SMN Gene Dosage on ALS Risk and Disease Severity (2021) (5)
- Modifying expression of EphA 4 and its downstream targets improves functional recovery after stroke (2013) (5)
- The pathogenesis of amyotrophic lateral sclerosis (1998) (4)
- Therapeutic Potential Of Selective Inhibition Of Histone Deacetylase 6 (hdac6) In Different Forms Of Cmt2 (2015) (4)
- STING-Induced Inflammation - A Novel Therapeutic Target in ALS? (2021) (4)
- Exposure of a cryptic Hsp70 binding site determines the cytotoxicity of the ALS-associated SOD1-mutant A4V. (2019) (4)
- Evidence for a pertussis toxin-sensitive signalling pathway in the dual action of angiotensin II on growth hormone release in pituitary cell aggregates. (1990) (4)
- NIPA 1 polyalanine repeat expansions are associated with amyotrophic lateral sclerosis (2012) (4)
- The SOD1-mediated ALS phenotype shows a decoupling between age of symptom onset and disease duration (2022) (3)
- Genetic markers of ALS (2000) (3)
- Deletion of the hypoxia-response element in the VEGF promoter causes adult onset motor neuron degeneration (2002) (3)
- Synaptopodin and 4 novel genes identified in primary sensory neurons (2005) (3)
- Molecular dynamics analysis of Superoxide Dismutase 1 mutations suggests decoupling between mechanisms underlying ALS onset and progression (2022) (2)
- Identification and characterization of Nanobodies targeting the EphA 4 receptor (2017) (2)
- Excitotoxicity and oxidative stress in the pathogenesis of amyotrophic lateral sclerosis/motor neuron disease (2003) (2)
- Deletion or Inhibition of th e Oxygen Sensor PHD 1 Protects against Ischemic Stroke via Reprogramming of Neuronal Metabolism Graphical (2016) (2)
- Vascular versus neuronal defects in ALS: an fMRI and DTI study (2006) (2)
- CAMTA 1 Gene With Survival in Patients With Sporadic Amyotrophic Lateral Sclerosis (2018) (2)
- New treatment strategies in amyotrophic lateral sclerosis: solutions or illusions? (1995) (2)
- A case of hemiparesis with cranial nerve lesions (2003:4a) (2003) (2)
- Novel Gender Selective Survival Effect of C9orf72 in European ALS Cohorts (P5.093) (2016) (2)
- MRI of transverse sinus thrombosis. (1989) (2)
- Evidence for Regulatory Cell-to-Cell Communication with Gonadotrophs, Lactotrophs, and Folliculostellate Cells in Rat Pituitary Cell Aggregates (1987) (1)
- 49 – Cell-to-Cell Communication in Peptide Target Cells of Anterior Pituitary (1989) (1)
- Validity and reliability of the German language SF-36 health survey in patients with amyotrophic lateral sclerosis (2002) (1)
- Rapamycin increases survival in ALS mice lacking mature lymphocytes (2013) (1)
- Transgenic mouse and mutagenesis models (2021) (1)
- The contribution of Neanderthal introgression and natural selection to neurodegenerative diseases (2023) (1)
- An unusual presentation of Guillain–Barré syndrome associated with monospecific anti-GD1b antibodies (2010) (1)
- G.O.1 In vitro expression of small heat shock protein HSPB8 and HSPB1 mutations causing axonal neuropathy (2006) (1)
- [A man with plasma cell dyscrasia and polyneuropathy due to POEMS syndrome]. (2002) (1)
- Tubular aggregates in muscle biopsies: three case studies (1998) (1)
- Chapter 10 Excitotoxicity and Oxidative Stress in Pathogenesis of Amyotrophic Lateral Sclerosis/Motor Neuron Disease (2003) (1)
- Progranulin modifies onset age and survival in amyotrophic lateral sclerosis (2007) (1)
- Lowering EphA4 Does Not Ameliorate Disease in a Mouse Model for Severe Spinal Muscular Atrophy (2019) (1)
- Neuroprotection in amyotrophic lateral sclerosis (1997) (1)
- Telomere length analysis in amyotrophic lateral sclerosis using large-scale whole genome sequence data (2022) (1)
- Chapter 19 Therapies in amyotrophic lateral sclerosis: Options for the near and far future. (2007) (1)
- Metabolic and contractile properties in skeletal muscles of a transgenic mouse model of amyotrophic lateral sclerosis (2002) (1)
- The effect of Vascular Endothelial Growth Factor (VEGF) on Motoneuron Degeneration (2003) (0)
- Upper Motor Neuron and Extramotor White Matter Involvement in Phenotypes of Recent Onset Motor Neuron Disease; a Longitudinal Diffusion Tensor Study Using Voxel-Based Analyses (2010) (0)
- Exome array analysis of rare and low frequency variants in amyotrophic lateral sclerosis (2019) (0)
- VEGF is a modifier gene of amyotrophic lateral sclerosis in humans (2003) (0)
- Südeck atrophy with painful muscle spasms: central or peripheral disease? (1988) (0)
- Polyglucosan body myopathy. A case report (1999) (0)
- Report from the Italian Ministerial Committee regarding the diagnosis, care and assistance of patients with ALS (2005) (0)
- DISRUPTED AXONAL TRANSPORT IN A MOUSE MODEL OF MUTANT HSPB1-INDUCED CHARCOT-MARIE-TOOTH DISEASE TYPE 2F (2011) (0)
- From El Escorial to Awaji: where do we go next with the amyotrophic lateral sclerosis criteria? (2012) (0)
- Efficacy and safety of intravenous immunoglobulin IgPro10 in CIDP: Combination of PRIMA and PATH studies (2018) (0)
- Demographic characteristics of a Belgian ALS population (1996) (0)
- University of Groningen Mapping of Gene Expression Reveals CYP 27 A 1 as a Susceptibility Gene for Sporadic (2012) (0)
- Reduction of ephrin-A5 aggravates disease progression in amyotrophic lateral sclerosis (2019) (0)
- Genomic characterization of the C9orf72 promoter repeat in FTLD and ALS patients (2012) (0)
- C9ORF72 repeat expansions cause axonal transport defects in iPSC-derived motor neurons (2016) (0)
- Joint opening and closing plenary sessions reflect on the continued need for new treatments and the hurdles that must be overcome in order for a drug to reach clinical trials. Introduction. (2014) (0)
- Differences in polysomnographic data of patients with neural disease versus isolated muscular disease (1998) (0)
- Visual loss as the presenting sign in spinocerebellar ataxia type 7 (SCA7) (2004) (0)
- Can the thoracic-abdominal thrust manoeuvre (TATM) ameliorate cough in amyotrophic lateral sclerosis (ALS)? (2007) (0)
- Advances in amyotrophic lateral sclerosis - Papers from the 10th International Symposium on Amyotrophic Lateral Sclerosis/Motor Neuron Disease held in Vancouver on November 15-17 November, 1999 - Preface (2000) (0)
- 046 Efficacy and safety of intravenous immunoglobulin (IVIG) IGPRO10 in chronic inflammatory demyelinating polyneuropathy (CIDP) (2018) (0)
- HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUS-ALS patients (2017) (0)
- Preface (2000) (0)
- Absence of association between a risk gene for myocardial infarction and common stroke (2008) (0)
- ARSACS cause atypical and late-onset forms of SACS Mutations in (2010) (0)
- Improved results of voxel-based DTI analyses by using non-rigid coregistration and a population-based DTI atlas (2008) (0)
- Development of Improved HDAC6 Inhibitors as Pharmacological Therapy for Axonal Charcot–Marie–Tooth Disease (2016) (0)
- Corrigendum to “Synaptopodin and 4 novel genes identified in primary sensory neurons” [Mol. Cell. Neurosci. 30 (2005) 316–325] (2006) (0)
- Efficacy and Safety of Intravenous Immunoglobulin (IVIG) IgPro10 in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): the PRIMA and PATH studies (P1.153) (2018) (0)
- Endoplasmic reticulum calcium release in motor neurons does not affect survival in a murine model of Amyotrophic Lateral Sclerosis (2010) (0)
- Genome-wide structural variant analysis identifies risk loci for non-Alzheimer’s dementias (2023) (0)
- Tau doesn't contribute to the pathogenesis of amyotrophic lateral sclerosis (2008) (0)
- Elongator Protein 3 controls synaptic transmission by restricting active zone size (2010) (0)
- Treatment of an aggressive form of motor neuron degeneration by VEGF protein and gene transfer in ALS animal models (2004) (0)
- Preface (2001) (0)
- Pulsed arterial spin labeling of hypo- and hyperventilated mice (2010) (0)
- Short communication TNFRSF1A coding variants in multiple sclerosis (2011) (0)
- Combined genome-wide analysis identifies UNC13A and chromosome 9P21.1 as shared loci for susceptibility to amyotrophic lateral sclerosis and frontotemporal lobar degeneration (2011) (0)
- A transgenic animal model for Charcot-Marie-Tooth disease caused by mutations in HSPB1 shows length-dependent muscle weakening and atrophy due to axonal loss (2009) (0)
- Mutations in the Glycosylt ransferase Domain of GLT 8 D 1 Are Associated with Familial Amyotrophic Lateral Sclerosis Graphical (2019) (0)
- THE ROLE OF HISTONE DEACETYLASE 6 (HDAC6) IN MUTANT GLYCYL-TRNA SYNTHETASE (GARS) AND MUTANT SMALL HEAT SHOCK PROTEIN B1 (HSPB1)-INDUCED AXONAL CHARCOT-MARIE-TOOTH DISEASE (CMT) (2016) (0)
- EphA4 loss improves social memory performance and alters dendritic spine morphology without changes in amyloid pathology in a mouse model of Alzheimer’s disease (2019) (0)
- Genomic Characterization of the C9orf72 Repeat Region Associated with FTLD and ALS (2012) (0)
- IP3R2 knockout is detrimental in a model of Amyotrophic Lateral Sclerosis (2010) (0)
- T.I. 2 Molecular and cellular therapies for amyotrophic lateral sclerosis (2006) (0)
- Progranulin is neurotrophic in vivo, stimulating functional recovery after nerve crush injury (2016) (0)
- Assessing white matter integrity with DTI in a large group of ALS patients (2006) (0)
- Development of a SPE-LC-UV method for analysis of MPB in brain and spinal cord (2012) (0)
- Ubiquitous knockout of IP3R2 in is detrimental in a murine model of Amyotrophic Lateral Sclerosis (2011) (0)
- Progranulin reduces insoluble TDP-43 levels, slows down axonal degeneration and prolongs survival in mutant TDP-43 mice (2018) (0)
- Amyotrophic lateral sclerosis: pathogenesis. (2000) (0)
- Genetics of amyotrophic lateral sclerosis. (2000) (0)
- Enhancing Speech for BiPap Users Respiratory Management (2010) (0)
- Prevention of intestinal obstruction reveals progressive neurodegeneration in mutant TDP-43 (A315T)mice (2014) (0)
- Glial Activation in Amyotrophic Lateral Sclerosis (2007) (0)
- The role of placental growth factor in the nervous system (2008) (0)
- Genetic ablation of IP3R2 is detrimental in a murine model of Amyotrophic Lateral Sclerosis (2011) (0)
- L 7 . 3 Th 2 lymphocytes selectively expressed CaV 1 channels that may represent a therapeutic target in allergic diseases (2010) (0)
- No evidence for common genetic variants shared between multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS) (2011) (0)
- Author and Subject Index (2006) (0)
- Benefit of the Awaji diagnostic algorithm for ALS, a prospective study (2011) (0)
- Hyaline body myopathy: a rare cause of adult-onset weakness (1998) (0)
- ApoE and SMN genotypes in sporadic amyotrophic lateral sclerosis (1996) (0)
- Special Issue - Advances in Amyotrophic Lateral Sclerosis - Preface (2001) (0)
- Survival of SOD1-G93A mice is not affected by endoplasmic reticulum calcium release in motor neurons (2010) (0)
- Journal of the Neurological Sciences: Preface (2001) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Wim Robberecht?
Wim Robberecht is affiliated with the following schools:
